Health
Covid-19 impact on Non-Small Cell Lung Cancer Market Business Opportunities, Analysis and Overview by 2026 | Agennix AG, AstraZeneca, Eli Lily, GlaxoSmithKline – The Courier
” Toronto, Canada: – Global Non-Small Cell Lung Cancer Market is valued at USD 7.53 Billion (€ 6.47 Bn) in 2019 and expected to reach USD 12.89 Billion (€ 11.08…
“
Toronto, Canada: Global Non-Small Cell Lung Cancer Market is valued at USD 7.53 Billion ( 6.47 Bn) in 2019 and expected to reach USD 12.89 Billion ( 11.08 Bn) by 2026 with the CAGR of 7.9 % over the forecast period.
Scope of the reportThis report analyses the global market for Non-Small Cell Lung Cancer. The report will enable the user to understand and gain insights into the current and forecast market situation. The market is comprehensively analyzed by geography to give complete information…
-
General23 hours agoDonald Trump’s initial 10 per cent tariff takes effect
-
General22 hours agoJaguar Land Rover in UK pauses shipments to US
-
General19 hours agoTexas opens probe into Kellogg’s health claims, dyes
-
General18 hours agoAustralian share market set to dive as threat of US recession grows